+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 1Month - 60Years
All Genders
ID04802707

Phase II Open-Label Study Evaluating Oral Deoxycytidine and Deoxythymidine Treatment for Children and Adults with Mitochondrial Depletion Disorders Assessing Safety, Tolerability, and Efficacy

Led by Kenneth Myers, MD · Updated on 2026-10-19

200

Participants Needed

1

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Mitochondrial DNA depletion syndromes MDS are a group of inherited disorders that cause severe reduction in mitochondrial DNA, leading to problems with energy production in various tissues. These disorders are caused by mutations in certain nuclear genes and present with diverse symptoms affecting muscles, the brain, liver, and digestive system. There is currently no effective treatment for MDS, and care mainly focuses on managing symptoms. Research suggests that increasing specific deoxyribonucleosides might help prevent mitochondrial DNA depletion. This phase II open-label trial studies the safety, tolerability, and effectiveness of a combination of two deoxynucleosides, deoxycytidine and deoxythymidine, given orally daily to children and adults aged 0 to 60 years with confirmed MDS and mutations in specific genes. The dosage increases weekly from 100 mgkg to 400 mgkg over approximately 5 years. The study aims to provide early treatment to restore mitochondrial function and improve clinical outcomes. Participants will undergo regular clinical and neurological evaluations using mitochondrial disease scales, seizure diaries, and quality of life questionnaires. Laboratory tests will monitor blood counts, liver and kidney function, muscle damage markers, mitochondrial DNA levels, and mitochondrial function through various blood and urine tests. Safety is assessed by tracking adverse events, including diarrhea and any serious effects, throughout the treatment period. The total participation duration can extend up to 5 years.

CONDITIONS

Brief Title

Deoxynucleosides Pyrimidines as Treatment for Mitochondrial Depletion Syndrome

Research Team

K

Kenneth Alexis MD Myers, MD PhD FRCPC

S

Saoussen Dr Berrahmoune, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here